Skip to main content

Hypertension and Cardiovascular Disease

Content of the course:
An interactive course on hypertension and vardiovascular disease with focus on the brain, cognition, stroke and sympathetic nervous system activity. Bridging latest research and daily clinic. All participants will get the opportunity to present their own PhD project or research results in small interactive groups and get professional feedback on content and presentation technique..

Aim of the course:
The aim of the course is: 
1) To increase knowledge about the latest research in hypertension and cardiovascular disease. 
2) To improve presentation technique and receive constructive criticism of own research with the possible improvement of own research. 
3) To strengthen relationships with other research groups within hypertension and cardiovascular disease improving research/social networks.


ECTS-credits: 2,5

Dates: September 19-21, 2019

Course Venue: Hotel Almond, Gdańsk, Poland

Course language: English

Deadline for application: 1 April 2019

Course fee:
The Registration fee: 400 EUR
Price includes taxes.
The registration fee includes:
• hotel accommodation (2 nights)
• all meals
• refreshments during breaks
• access to the conference materials

The course is free of charge for PhD students enrolled in The Faculty of Health Sciences, The University of Southern Denmark.


September 19, 2019 THURSDAY
(at the Medical University of Gdansk)
10:00-10:30 Registration, coffee
10:30-11:30 Welcome, introduction, program presentation; presentation of participants and
national representatives
Krzysztof Narkiewicz (Poland): A short introduction on the relationship between
hypertension, brain, cognition and stroke

Day 1. Epidemiology, genetics and mechanisms of hypertension and its complications

11:30-12:25 Session 1
Worldwide trends in blood pressure and other risk factors: implications for future
cardiovascular disease mortality. Piotr Bandosz (Poland) (20 min)
Epidemiology of hypertension: novel insights from the Finn-Home Study and the
Framingham Heart Study. Teemu Niiranen (Finland) (20 min)
Discussion (15 min)

12:25-13:40 Session 2
Genetic and molecular background of hypertension in the post-GWAS era. Maciej
Tomaszewski (U.K.) (20 min)
The early life influences on neuroendocrine and nervous function. Peter Nilsson (Sweden) (20
Vasopressin, an endocrine link between cardiometabolic risk and the brain? Olle Melander
(Sweden) (20 min)
Discussion (15 min)

13:40-14:30 Lunch

14:30-15:30 Visit to the research facility of the Medical University of Gdansk (including
functional MRI)

15.30-16.30 Session 3
Arterial damage and cognitive decline in chronic kidney disease patients. Marius Miglinas
(Lithuania) (20 min)
Blood pressure variability and risk of cardiovascular endpoints with focus on cerebral stroke.
Eivind Berge (Norway) (20 min)
Discussion (20 min)

16:30-17:00 Break, coffee

17:00-19:00 Students´ project session 1
Project presentations and discussions in 4 parallel groups (with 5 faculty members in each

20:00 Dinner (combined with team building - surprise)

September 20, 2019 Friday (at the hotel)
Day 2: The integrated clinical approach – Treatment aspects

08:30-09:30 Session 4
Early versus late-onset hypertension. Teemu Niiranen (Finland) (20 min)
Do randomized controlled trials and observational data yield the same results? Mattias
Brunström (Sweden) (20 min)
Discussion (20 min)

09:30-10:30 Session 5
Renin-angiotensin-aldosterone system and cerebrovascular disease – Mucha Steckelings
How does blood pressure control influence the benefits of anticoagulant therapy ?
Thomas Kahan (Sweden)
Discussion (20 min)

10:30-11:00 Break, coffee

11:00-12:00 Session 6
Treatment of acute stroke – insights from the SCAST Study. Eivind Berge (Norway) (20 min)
Blood pressure in acute ischemic stroke: challenges in trial interpretation and clinical
management. Dariusz Gąsecki (Poland) (20 min)
Discussion (20 min)

12:00-13:00 Session 7
Blood pressure control after the stroke: does the type of stroke matter?. Karlis Trusinskis
Why we need multidisciplinary care in vascular disease and stroke ? Anders Gottsäter
Discussion (20 min)

13:00-14:00 Lunch

14:00-15:00 Session 8
Telemedicine and E-health in hypertension management. Margus Viigimaa (Estonia)
(20 min)
Mobile-based hypertension application. Michael Hecht Olsen (Denmark) (20 min)
Discussion (20 min)

15:00-16:00 Session 9: Pro-Con debates
postulate that ”the design of SPRINT, with incident heart failure included in the primary
endpoint, prohibited showing a difference in cerebral stroke despite a major difference in
blood pressure". Pro (attack): Sverre E. Kjeldsen (Norway), Con (defence): All Ph.D.
Students. Moderator: Maciej Tomaszewski (U.K.)
Pro-Con debate 2. Student debaters

16:00-16:30 Break, coffee

16:30-18:30 Students´ project session 2
Project presentations and discussions in 4 parallel groups (with 5 faculty members in each

19:00 Social program and dinner

September 21, 2019 SATURDAY (at the hotel)
Day 3. The brain and nervous system in perspective

08:15-09:15 Session 10
Sympathetic nervous system and hypertension: old theory - new data. Alexandra Konradi
Device-based hypertension therapy: focus on autonomic modulation. Dagmara Hering
(Poland) (20 min)
Discussion (20 min)

09:15-10:15 Session 11
Potassium, blood pressure and stroke: epidemiological and mechanistic relationships. Jørgen
Jeppesen (Denmark)
Sympathetic activation and the heart: from stroke to Takotsubo syndrome. Jonas Spaak
Discussion (20 min)

10:15-10:45 Break, coffee

10:45-12:45 Students´ project session 3
Project presentations and discussions in 4 parallel groups (with 5 faculty members in each

12:45-14:15 Session 16
Interventions improving drug adherence in hypertension. Maciej Tomaszewski (UK)
State-of-the-art Lecture: Reversibility of Early Vascular Aging - EVA: to what extent?
Stephane Laurent (France)

14:15 -15:00
Course summary

Last Updated 26.03.2019